Tiverton Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Tiverton Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-926	Closed	-$60K	–	524
2018 Q1	$60K	Sell	926 -2,757	-75%	-$195K	﹤0.01%	437
2017 Q4	$269K	Sell	3,683 -2,617	-42%	-$216K	0.02%	320
2017 Q3	$577K	Sell	6,300 -799	-11%	-$61.3K	0.03%	163
2017 Q2	$470K	Sell	7,099 -2,363	-25%	-$293K	0.03%	169
2017 Q1	$2.05M	Hold	9,462	–	–	0.11%	159
2016 Q4	$875K	Sell	9,462 -5,221	-36%	-$588K	0.05%	173
2016 Q3	$1.99M	Sell	14,683 -17,407	-54%	-$1.73M	0.16%	126
2016 Q2	$18.2M	Buy	32,090 +343	+1%	+$42.5K	0.77%	47
2016 Q1	$5.2M	Sell	31,747 -2,981	-9%	-$604K	0.18%	108
2015 Q4	$11.4M	Sell	34,728 -21,050	-38%	-$6.85M	0.36%	87
2015 Q3	$18M	Hold	55,778	–	–	0.4%	73
2015 Q2	$22.2M	Buy	55,778 +16,889	+43%	+$7.18M	0.44%	71
2015 Q1	$19.1M	Sell	38,889 -5,555	-12%	-$2.15M	0.39%	81
2014 Q4	$15.9M	Hold	44,444	–	–	0.33%	86
2014 Q3	$8.57M	Hold	44,444	–	–	0.2%	99
2014 Q2	$10.6M	Hold	44,444	–	–	0.24%	93
2014 Q1	$11.4M	Sell	44,444 -11,112	-20%	-$3.4M	0.25%	96
2013 Q4	$11M	Hold	55,556	–	–	0.24%	95
2013 Q3	$9.39M	Hold	55,556	–	–	0.23%	93
2013 Q2	$9.86M	Buy	+55,556	New	+$7.87M	0.26%	88

Other funds holding LUMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tiverton Asset Management's LUMO Position: Q2 2018 in Review

Tiverton Asset Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 926 shares — an estimated $60K sold.

Tiverton Asset Management first reported a position in LUMO in Q2 2013 and held it in 20 quarters. The position peaked at $22.2M in Q2 2015. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

Tiverton Asset Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Tiverton Asset Management sold 926 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $60K.
Tiverton Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 20 quarters.
Tiverton Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $22.2M in Q2 2015.
106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on Tiverton Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.